Busulfan
بوسولفان
🎗️ Antineoplastic And Immunomodulating AgentsAlkylating agent
Market / country: 🇺🇸 USA
Myleran (US)
🧮 Dose calculator
Chronic myeloid leukaemia (CML) · Regimen source: FDA Myleran · Dosage and Administration
- • WBC fall is dose-related; above 4 mg/day only if response is insufficient. Children: same weight-based dose. Weekly counts. FDA Myleran · Dosage and Administration
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ CML diagnosis not firmly established; prior hypersensitivity to busulfan. FDA Myleran · Contraindications
Warnings
- • Bone-marrow failure and prolonged pancytopenia; pulmonary fibrosis; secondary malignancy. FDA Myleran · Warnings
Formulations
- 2 mg tablet — tablet 🇺🇸 USA FDA Myleran · How Supplied
👥 Special populations
- 🤰 PregnancyDangerous / avoid
Label: can cause fetal harm. Dangerous in pregnancy. FDA Myleran · Pregnancy
“Busulfan may cause fetal harm when administered to a pregnant woman.”
- 🤱 BreastfeedingDangerous / avoid
Label: breastfeeding not recommended, or choose between the drug and breastfeeding. FDA Myleran · Lactation
“Because of the potential for tumorigenicity shown for busulfan in animal and human studies, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Myleran · Pediatric Use
“See INDICATIONS AND USAGE and DOSAGE AND ADMINISTRATION sections.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Myleran · Geriatric Use
“In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)NDA009386
- DailyMed (FDA label)FDA Myleran
- MedlinePlus (NIH)BusulfanBusulfan Injection
- WHO ATC/DDDL01AB01
- Darooyab (Iran)Busulfan
🇮🇷 Registered in Iran Darooyab · G-960/Busulfan
Dosage forms with Iranian generic codes, per Darooyab.
- 00186 · BUSULFAN 2MG TAB · قرص بوسولفان ۲ میلیگرم
- 06700 · BUSULFAN 6MG/ML AMP · آمپول بوسولفان ۶ میلیگرم / میلیلیتر
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Myleran · How SuppliedFDA Myleran · Dosage and AdministrationFDA Myleran · ContraindicationsFDA Myleran · WarningsFDA Myleran · PregnancyFDA Myleran · LactationFDA Myleran · Pediatric UseFDA Myleran · Geriatric UseFDA Myleran · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-960/Busulfan
- Clinical review⚠ Unverified